Incomplete Kawasaki Disease Presenting with Pancarditis and Pericardial Effusion

Öz

Kawasaki disease is an acute self-limiting systemic vasculitis. Although its etiology is unknown, some infectious agents are strongly suspected. Untreated patients may develop severe complications, such as coronary artery aneurysm, congestive heart failure, myocardial infarction, and cardiac dysrhythmia. In this report, eight years-old girl, diagnosed as incomplete KD with pericardial effusion without conjunctivitis and lymphadenopathy, was presented.

Key words:  Incomplete Kawasaki disease, Pancarditis, Pericardial effusion

Anahtar Kelimeler

• Incomplete Kawasaki disease, Pancarditis, Pericardial effusion

Pankardit ve Perikardiyal Efüzyon ile Presente Olan İnkomplet Kawasaki Hastalığı

Öz

Kawasaki hastalığı akut, kendini sınırlayan sistemik bir vaskülittir. Etyolojisi kesin olarak bilinmemekle birlikte enfeksiyon ajanlarından şüphelenilmektedir. Tedavi edilmemiş hastalarda koroner arter anevrizması, konjestif kalp yetmezliği, miyokardiyal enfarktüs ve aritmi gibi komplikasyonlar gelişebilmektedir. Bu yazıda perikardiyal efüzyonu olup konjonktivit ve lenfadenopatisi olmayan inkomplet Kawasaki hastalığı tanısı konulan sekiz yaşında kız olgu sunulmuştur.

Anahtar kelimeler: İnkomplet Kawasaki hastalığı, Pankardit, Perikardial efüzyon

Anahtar Kelimeler

• İnkomplet Kawasaki hastalığı, Pankardit, Perikardial efüzyon

Kaynakça

1. Freeman AF, Shulman ST, Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 2006 1;74:1141-8.
2. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178–222.
3. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa HA. New infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
4. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 2000;154:453-6.
5. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.
6. Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS. Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 2012;171:657-62.
7. Dahlem PG, von Rosenstiel IA, Lam J, Kuijpers TW. Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease. Intensive Care Med 1999;25:1137-9.
8. Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, et al. Kawasaki disease in families. Pediatrics 1989;84:666-9.

9. Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007;49:421-6
10. Sonçaği A, Devrim I, Karagöz T, Dilber E, Celiker A, Ozen S, et al. Septated pericarditis associated with Kawasaki disease: a brief case report. Turk J Pediatr 2007;49:312-4.
11. Chantepie A, Mauran P, Lusson JR, Vaillant MC, Bozio A. Cardiovascular complications of Kawasaki syndrome: results of a French multicenter study Arch Pediatr 2001;8:713-9.
12. Salice P, Pietrogrande MC, Barbier P, Ghiglia S, Laicini E, Fesslova V. [Cardiovascular abnormalities in Kawasaki disease. An Italian prospective study]. Cardiologia. 1998;43:1367-74.
13. Ozdogu H, Boga C. Fatal cardiac tamponade in a patient with Kawasaki disease. Heart Lung 2005;34:257-9.